News

Regulatory affairsRegulatory Round-up - March 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Early seed lot and clinical grade iPS cell line from the Cell and Gene Therapy CatapultEarly seed lot and clinical grade iPS cell line from the Cell and Gene Therapy CatapultLord Prior visits London offices and laboratoriesLord Prior visits London offices and laboratoriesRegulatory news - December 2016Regulatory news - December 2016Regulatory news - November 2016Regulatory news - November 2016Keith Thompson, CEO, speaks to Manufacturing ChemistKeith Thompson, CEO, speaks to Manufacturing ChemistAdvanced Therapies Manufacturing Taskforce report publishedAdvanced Therapies Manufacturing Taskforce report publishedPress release: Autolus to manufacture at the Cell and Gene Therapy CatapultPress release: Autolus to manufacture at the Cell and Gene Therapy CatapultRegulatory news: October 2016Regulatory news: October 2016Manufacturing centre update: Why Stevenage?Manufacturing centre update: Why Stevenage?News: Alliance for Regenerative Medicine Submits CommentsNews: Alliance for Regenerative Medicine Submits CommentsRegulatory news: September 2016Regulatory news: September 2016News: Cell and Gene Therapy Catapult welcomes Innovate UK’s new competition for the industrialisation of manufacture of cell and gene therapiesNews: Cell and Gene Therapy Catapult welcomes Innovate UK’s new competition for the industrialisation of manufacture of cell and gene therapies